Talking the Cure by Hogan Lovells Podcast

Pharma – The Last Word – Breaking Barriers: The FDA’s Evolving Approach to Biosimilars and Interchangeability	Talking the Cure by Hogan Lovells	22:28
Drafting the Future: Unpacking the FDA's Clinical Trial Diversity Action Plan	Talking the Cure by Hogan Lovells	14:03
Pharma – The Last Word – Early Access Unlocked, navigating EU programs for pre-approval drug access	Talking the Cure by Hogan Lovells	17:40
Pharma – The Last Word – Regulatory and legal trends in the pharma and biotech industries	Talking the Cure by Hogan Lovells	13:14
Pharma – The Last Word - The inaugural episode	Talking the Cure by Hogan Lovells	07:37
Securing the Crown Jewels: Navigating IP and cybersecurity in the life science industry	Talking the Cure by Hogan Lovells	32:27
Discussing UK medical device regulations	Talking the Cure by Hogan Lovells	17:07
Talking the Cure - Exploring the industry with Richard Backhaus and Lars Cornels (Drägerwerk AG & Co. KGaA) - Part 2	Talking the Cure by Hogan Lovells	27:19
Talking the Cure - Exploring the industry with Richard Backhaus and Lars Cornels (Drägerwerk AG & Co. KGaA) - Part 1	Talking the Cure by Hogan Lovells	29:24
Talking the Cure - Exploring the industry with Robert F. Church	Talking the Cure by Hogan Lovells	36:30
Talking the Cure - Exploring the industry with Alice Valder Curran	Talking the Cure by Hogan Lovells	39:08
Talking the Cure - Exploring the industry with Randy Prebula	Talking the Cure by Hogan Lovells	46:28
Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)	Talking the Cure by Hogan Lovells	31:28
Talking the Cure - Discussing latest developments іn clinical trials diversity, driven by FDORA	Talking the Cure by Hogan Lovells	19:58
Talking the Cure - Discussing Artificial Intelligence in Medical Devices	Talking the Cure by Hogan Lovells	34:45
Talking the Cure - Discussing MedTech Color with Kwame Ulmer	Talking the Cure by Hogan Lovells	21:18
Talking the Cure - Exploring the industry with Ina Brock	Talking the Cure by Hogan Lovells	48:44
Talking the Cure - Discussing diversity in clinical trials	Talking the Cure by Hogan Lovells	36:02
Talking the Cure - Discussing the repurpose of existing UK offices/retail to laboratory space?	Talking the Cure by Hogan Lovells	32:09
Talking the Cure - Discussing what’s on the horizons for orthopedic devices	Talking the Cure by Hogan Lovells	31:26
Talking the Cure - Exploring the industry with Andreas von Falck	Talking the Cure by Hogan Lovells	34:34
Talking the Cure: Discussing Digital Health Applications in Germany	Talking the Cure by Hogan Lovells	34:44
Talking the Cure - Exploring the industry with Jonathan S. Kahan	Talking the Cure by Hogan Lovells	44:37
Talking the Cure: Discussing Early Access Programs (EAPs) in the US and Germany	Talking the Cure by Hogan Lovells	33:18
Talking The Cure: Exploring the industry with Christian Di Mauro	Talking the Cure by Hogan Lovells	30:10
Talking The Cure: Discussing return to work policies, testing at work sites, and vaccinations	Talking the Cure by Hogan Lovells	33:14
Talking The Cure: Exploring the industry with Lowell Zeta	Talking the Cure by Hogan Lovells	30:59
Talking The Cure: Discussing the impact of Covid-19 on cell, tissue, and gene therapy products	Talking the Cure by Hogan Lovells	53:30
Talking The Cure: Discussing advertising and promotion of COVID-19 test kits	Talking the Cure by Hogan Lovells	39:50
Talking The Cure: Discussing hand sanitizers and their way to the market	Talking the Cure by Hogan Lovells	31:18
Talking The Cure: Discussing the current ”surge” of Digital Health Innovations in Europe	Talking the Cure by Hogan Lovells	52:47
Talking The Cure: Exploring the industry with Jodi Scott	Talking the Cure by Hogan Lovells	29:51
Talking The Cure: Exploring the industry with the leads of our associate committee	Talking the Cure by Hogan Lovells	40:35
Talking The Cure: Discussing artificial intelligence in drug discovery and the possible legal issues that result from this usage.	Talking the Cure by Hogan Lovells	38:16
Talking The Cure: Discussing in vitro diagnostics (IVD) in times of a pandemic	Talking the Cure by Hogan Lovells	34:43
Talking The Cure: Exploring the industry with Jonathan Wasserman	Talking the Cure by Hogan Lovells	37:26
Talking The Cure: Discussing the “Buy America” Executive Order	Talking the Cure by Hogan Lovells	54:27
Talking The Cure: Discussing opportunities and risks for international digital health companies engaging in Germany	Talking the Cure by Hogan Lovells	35:58
Talking The Cure: Discussing innovation in drug development, the competitive aspects and affordability of medicines in Europe	Talking the Cure by Hogan Lovells	14:51
Talking The Cure: Discussing recent industry developments with the Hogan Lovells Sciences Unit	Talking the Cure by Hogan Lovells	44:32

Pharma – The Last Word – Breaking Barriers: The FDA’s Evolving Approach to Biosimilars and Interchangeability

Talking the Cure by Hogan Lovells

22:28

Drafting the Future: Unpacking the FDA's Clinical Trial Diversity Action Plan

Talking the Cure by Hogan Lovells

14:03

Pharma – The Last Word – Early Access Unlocked, navigating EU programs for pre-approval drug access

Talking the Cure by Hogan Lovells

17:40

Pharma – The Last Word – Regulatory and legal trends in the pharma and biotech industries

Talking the Cure by Hogan Lovells

13:14